MX343796B - Metodos para administrar un material en un paciente para realce dermico. - Google Patents

Metodos para administrar un material en un paciente para realce dermico.

Info

Publication number
MX343796B
MX343796B MX2012012220A MX2012012220A MX343796B MX 343796 B MX343796 B MX 343796B MX 2012012220 A MX2012012220 A MX 2012012220A MX 2012012220 A MX2012012220 A MX 2012012220A MX 343796 B MX343796 B MX 343796B
Authority
MX
Mexico
Prior art keywords
patient
methods
soft tissue
dermal enhancement
administering
Prior art date
Application number
MX2012012220A
Other languages
English (en)
Inventor
M Burgess Cheryl
Original Assignee
M Burgess Cheryl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M Burgess Cheryl filed Critical M Burgess Cheryl
Publication of MX343796B publication Critical patent/MX343796B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a el uso de un factor de coagulación que consiste de: (1) rhFII, (2) una combinación de rhFII, rhFVIIa y rhFX, (3) fibrinógeno y una combinación de rhFII, rhFVII a y rhFX, (4) fibrinógeno y rhFII, (5) una combinación de rhFII y rhFVIIa y (6) fibrinógeno y una combinación de rhFII y rhFVIIa para la preparación de un medicamento para usarse en normalizar la hemostasis alterada asociado con coagulopatía dilucional en un mamífero, en donde el medicamento no comprende otros factores de coagulación de entre los factores de coagulación FV-FXIII.
MX2012012220A 2003-03-13 2004-03-08 Metodos para administrar un material en un paciente para realce dermico. MX343796B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45396603P 2003-03-13 2003-03-13
PCT/US2004/006875 WO2004082459A2 (en) 2003-03-13 2004-03-08 Methods of administering a material into a patient for dermal enhancement

Publications (1)

Publication Number Publication Date
MX343796B true MX343796B (es) 2016-11-23

Family

ID=33029862

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2012012220A MX343796B (es) 2003-03-13 2004-03-08 Metodos para administrar un material en un paciente para realce dermico.
MXPA05009803A MXPA05009803A (es) 2003-03-13 2004-03-08 Metodos para administrar un material en un paciente para realce dermico.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MXPA05009803A MXPA05009803A (es) 2003-03-13 2004-03-08 Metodos para administrar un material en un paciente para realce dermico.

Country Status (5)

Country Link
US (2) US7637900B2 (es)
EP (1) EP1610674A4 (es)
CA (1) CA2519120C (es)
MX (2) MX343796B (es)
WO (1) WO2004082459A2 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050226936A1 (en) 2004-04-08 2005-10-13 Q-Med Ab Method of soft tissue augmentation
US7389044B2 (en) * 2004-08-11 2008-06-17 Alcatel-Lucent Canada Inc. Method and system for providing a signature signal in an optical network in the event of loss of a client
US7850683B2 (en) 2005-05-20 2010-12-14 Myoscience, Inc. Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat)
US7713266B2 (en) 2005-05-20 2010-05-11 Myoscience, Inc. Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat)
WO2007046103A2 (en) * 2005-10-19 2007-04-26 Perf-Action Technologies Ltd. System for iontophoretic transdermal delivery of polymeric agents and methods of use thereof
US20070212385A1 (en) * 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
KR20090038025A (ko) * 2006-08-02 2009-04-17 코리오닉스 조직 보강 및 반흔 형성에 특히 유용한 이식용 제제
US8554830B2 (en) * 2006-09-06 2013-10-08 Devicescape Software, Inc. Systems and methods for wireless network selection
US20090124996A1 (en) * 2006-11-03 2009-05-14 Scott Heneveld Apparatus and methods for injecting high viscosity dermal fillers
US9254162B2 (en) 2006-12-21 2016-02-09 Myoscience, Inc. Dermal and transdermal cryogenic microprobe systems
US8409185B2 (en) * 2007-02-16 2013-04-02 Myoscience, Inc. Replaceable and/or easily removable needle systems for dermal and transdermal cryogenic remodeling
US20080275403A1 (en) * 2007-05-04 2008-11-06 Armand Maaskamp Dual syringe assembly
US8672918B2 (en) * 2007-05-16 2014-03-18 Ipsyrng Capital Development, Llc Methods for identifying areas of a subject's skin that appear to lack volume
FR2918377B1 (fr) 2007-07-05 2010-10-08 Estelle Piron Gel co-reticule de polysaccharides
JP2010535071A (ja) * 2007-08-01 2010-11-18 ジョンズ ホプキンス ユニバーシティ 光開始組織充填剤
US8455459B2 (en) * 2007-08-02 2013-06-04 Medicis Pharmaceutical Corporation Method of applying an injectable filler
US20090204101A1 (en) * 2007-08-20 2009-08-13 Wortzman Mitchell S Method of applying an injectable filler
WO2009059121A1 (en) * 2007-11-02 2009-05-07 Genzyme Corporation Methods of augmenting or repairing soft tissue
WO2009065061A1 (en) 2007-11-14 2009-05-22 Myoscience, Inc. Pain management using cryogenic remodeling
WO2009086250A1 (en) 2007-12-21 2009-07-09 Aesthetic Sciences Corporation Self-contained pressurized injection device
US20100016829A1 (en) * 2008-07-15 2010-01-21 Krumme John F Apparatus and methods for retaining a needle on a medical injector
ES2829971T3 (es) 2008-09-02 2021-06-02 Tautona Group Lp Hilos de ácido hialurónico y/o derivados de los mismos, métodos para fabricar los mismos y usos de los mismos
AU2009330012A1 (en) 2008-12-22 2011-07-21 Myoscience, Inc. Integrated cryosurgical system with refrigerant and electrical power source
CN104159534B (zh) 2012-01-13 2017-02-22 肌肉科技股份有限公司 用于美容和其他处理的皮下低温重塑的皮肤保护
EP2802278B1 (en) 2012-01-13 2016-12-07 Myoscience, Inc. Cryogenic probe filtration system
WO2013106859A1 (en) 2012-01-13 2013-07-18 Myoscience, Inc. Cryogenic needle with freeze zone regulation
US9017318B2 (en) 2012-01-20 2015-04-28 Myoscience, Inc. Cryogenic probe system and method
US9199044B2 (en) * 2012-08-06 2015-12-01 Elwha Llc Devices and methods for wearable injection guides
US9629963B2 (en) 2012-10-30 2017-04-25 Elwha Llc Systems and methods for generating an injection guide
US10046119B2 (en) 2012-10-30 2018-08-14 Elwha Llc Systems and methods for generating an injection guide
US9610112B2 (en) 2013-03-15 2017-04-04 Myoscience, Inc. Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis
WO2014146126A1 (en) 2013-03-15 2014-09-18 Myoscience, Inc. Cryogenic blunt dissection methods and devices
US9295512B2 (en) 2013-03-15 2016-03-29 Myoscience, Inc. Methods and devices for pain management
WO2014146122A1 (en) 2013-03-15 2014-09-18 Myoscience, Inc. Methods and systems for treatment of occipital neuralgia
US10130409B2 (en) 2013-11-05 2018-11-20 Myoscience, Inc. Secure cryosurgical treatment system
WO2016070132A1 (en) * 2014-10-31 2016-05-06 Allergan, Inc. Method for improving duration of effect of dermal filler treatment
US9694145B1 (en) 2016-03-29 2017-07-04 Joseph Onorato Auto-injector systems and method for delivering cyst medication on demand
US10850137B2 (en) 2016-04-29 2020-12-01 Meghan K. McGovern Method of reshaping a body part
WO2017197323A1 (en) 2016-05-13 2017-11-16 Lee Ann S Methods and systems for locating and treating with cold therapy
US11134998B2 (en) 2017-11-15 2021-10-05 Pacira Cryotech, Inc. Integrated cold therapy and electrical stimulation systems for locating and treating nerves and associated methods
KR20210005945A (ko) 2018-05-03 2021-01-15 콜플랜트 리미티드 진피 충전제 및 이의 적용
USD893715S1 (en) 2018-11-06 2020-08-18 Joseph Onorato Measurement guide for a cyst, lesion or skin disorder
US11717638B2 (en) 2021-02-09 2023-08-08 Thuy Doan Method for anesthetizing the lips

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3841401A1 (de) 1988-12-08 1990-06-13 Martin Lemperle Alloplastisches implantat
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5241969A (en) * 1992-06-10 1993-09-07 Carson Jay W Controlled and safe fine needle aspiration device
BR9815713A (pt) * 1997-02-20 2002-11-05 Gerigene Medical Corp Método para aumento e reparo de defeitos de tecido dérmico, subcutâneo e das cordas vocais
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
US6306425B1 (en) * 1999-04-09 2001-10-23 Southern Research Institute Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
US6358917B1 (en) * 1999-08-24 2002-03-19 Jean D. A. Carruthers Cosmetic use of botulinum toxin for treatment of downturned mouth
NZ523461A (en) * 2000-05-31 2004-11-26 Encelle Inc Method of treating chronic ulcers
AU2001288585A1 (en) * 2000-08-30 2002-03-13 Wallace K. Dyer Methods and compositions for tissue augmentation

Also Published As

Publication number Publication date
US20040225276A1 (en) 2004-11-11
US7637900B2 (en) 2009-12-29
EP1610674A4 (en) 2008-05-21
CA2519120A1 (en) 2004-09-30
MXPA05009803A (es) 2006-04-18
EP1610674A2 (en) 2006-01-04
US8038665B2 (en) 2011-10-18
CA2519120C (en) 2017-11-07
WO2004082459A2 (en) 2004-09-30
US20100057218A1 (en) 2010-03-04
WO2004082459A3 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
MX343796B (es) Metodos para administrar un material en un paciente para realce dermico.
US10786601B2 (en) Composition comprising hyaluronic acid and mepivacaine
KR100759091B1 (ko) 피부 충전제 조성물
TW200612987A (en) Combination treatment for non-hematologic malignancies
KR101848957B1 (ko) 히알루론산 기반 제형
MX2009003737A (es) Composicion inyectable en deposito y su procedimiento de preparacion.
CN108210887A (zh) 一种医用冷敷贴及其制备方法
MX342613B (es) Geles con base de acido hialuronico que incluyen agentes anestesicos.
TW200501983A (en) Uses of anti-insulin-like growth factor I receptor antibodies
JP6827108B2 (ja) 皮膚充填剤用途のためのコアセルベートヒアルロナンヒドロゲル
KR102598044B1 (ko) 필러 조성물
JP2018504984A5 (es)
BR0313954A (pt) Composição de cerâmica biocompatìvel, dispositivo médico, método para fabricar uma composição de cerâmica biocompatìvel, implantes médico e ortopédico, material de enchimento dental ou implante dental, veìculo de droga para liberação de droga no corpo de um paciente, uso da composição de cerâmica biocompatìvel, método para gerar calor in vivo no corpo de um paciente para propósitos terapêuticos, e, método terapêutico
KR20170118105A (ko) 턱과 같은 얼굴 이목구비를 조각, 확대 또는 교정하기 위한 임플란트
RU2012134096A (ru) Гидрогель, содержащий микросферы
EP2407147A3 (en) Composition with bio-rigenerative, restorative and eutrophying activity
JP5671618B2 (ja) Ｐｇａを含んでなる新しいｅｍｄ製剤
WO2009148579A3 (en) Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system
Shab et al. Agarose gel-high patient satisfaction of a full-facial volume augmentation
TW200733897A (en) Oral product for moistening skin
KR20220141309A (ko) 아멜로게닌을 포함하는 조성물 및 이의 용도
JP2011037726A (ja) 殺菌性根管充填用シーラー及び調製用キット
AU745434B2 (en) Preparation for regenerating collagen
Juárez Biological effects of chitosan in Dentistry
AL-Bahar Evaluation the effect of incorporated hydroxyapatite prepared from dried egg shell on some properties of relined denture base